α-MSH regulates intergenic splicing of MC1R and TUBB3 in human melanocytes

Nucleic Acids Research

Volumn 39, Issue 6, 2011, Pages 2378-2392

  Dalziel, Martin ^a   Kolesnichenko, Marina ^a   Das Neves, Ricardo Pires ^b,c   Iborra, Francisco ^d   Goding, Colin ^e   Furger, André ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c Biocant Center of Innovation and Biotechnology   (Portugal)

^d CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BETA TUBULIN; BETA TUBULIN 3 PROTEIN; ISOPROTEIN; MELANOCORTIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL MEMBRANE; ENZYME ACTIVATION; GENE LOCUS; HUMAN; HUMAN CELL; MELANOCYTE; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; SKIN PIGMENTATION; ULTRAVIOLET RADIATION;

ALPHA-MSH; ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL MEMBRANE; HEK293 CELLS; HUMANS; MAP KINASE KINASE 6; MELANOCYTES; MICE; MOLECULAR SEQUENCE DATA; RECEPTOR, MELANOCORTIN, TYPE 1; RNA 3' END PROCESSING; RNA, MESSENGER; TUBULIN;

EUKARYOTA;

EID: 79953710861     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq1125     Document Type: Article

References (41)

1. Getting,S.J. (2006) Targeting melanocortin receptors as potential novel therapeutics. Pharmacol. Therapeut., 111, 1-15.
2. Lin,J.Y. and Fisher,D.E. (2007) Melanocyte biology and skin pigmentation. Nature, 445, 843.
3. García-Borrón,J.C., Sánchez-Laorden,B.L. and Jiménez-Cervantes,C. (2005) Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res., 18, 393-410.
4. Lalueza-Fox,C., Rompler,H., Caramelli,D., Staubert,C., Catalano,G., Hughes,D., Rohland,N., Pilli,E., Longo,L., Condemi,S. et al. (2007) A melanocortin 1 receptor allele suggests varying pigmentation among Neanderthals. Science, 318, 1453-1455. (Pubitemid 350208956)
5. Rees,J.L. (2004) The genetics of sun sensitivity in humans. Am. J. Hum. Genet., 75, 739-751.
6. Sulem,P., Gudbjartsson,D.F., Stacey,S.N., Helgason,A., Rafnar,T., Jakobsdottir,M., Steinberg,S., Gudjonsson,S.A., Palsson,A., Thorleifsson,G. et al. (2008) Two newly identified genetic determinants of pigmentation in Europeans. Nat. Genet., 40, 835-837.
7. Valverde,P., Healy,E., Jackson,I., Rees,J.L. and Thody,A.J. (1995) Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat. Genet., 11, 328-330.
8. Bishop,D.T., Demenais,F., Iles,M.M., Harland,M., Taylor,J.C., Corda,E., Randerson-Moor,J., Aitken,J.F., Avril,M.-F., Azizi,E. et al. (2009) Genome-wide association study identifies three loci associated with melanoma risk. Nat. Genet., 41, 920-925.
9. D'Orazio,J.A., Nobuhisa,T., Cui,R., Arya,M., Spry,M., Wakamatsu,K., Igras,V., Kunisada,T., Granter,S.R., Nishimura,E.K. et al. (2006) Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. Nature, 443, 340-344. (Pubitemid 44435153)
10. Mountjoy,K.G., Robbins,L.S., Mortrud,M.T. and Cone,R.D. (1992) The cloning of a family of genes that encode the melanocortin receptors. Science, 257, 1248-1251.
11. April,C.S. and Barsh,G.S. (2007) Distinct pigmentary and melanocortin 1 receptor-dependent components of cutaneous defense against ultraviolet radiation. PLoS Genet., 3, e9.
12. Steingrimsson,E., Copeland,N.G. and Jenkins,N.A. (2004) Melanocytes and the microphthalmia transcription factor network. Annu. Rev. Genet., 38, 365-411.
13. Hunt,G., Donatien,P.D., Lunec,J., Todd,C., Kyne,S. and Thody,A.J. (1994) Cultured human melanocytes respond to MSH peptides and ACTH. Pigment Cell Res., 7, 217-221.
14. Hunt,G., Todd,C., Cresswell,J.E. and Thody,A.J. (1994) Alpha-melanocyte stimulating hormone and its analogue Nle4DPhe7 alpha-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. J. Cell. Sci., 107(Pt 1), 205-211.
15. Wakamatsu,K., Graham,A., Cook,D. and Thody,A.J. (1997) Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res., 10, 288-297. (Pubitemid 127524305)
16. Dalziel,M., Nunes,N.M. and Furger,A. (2007) Two G-rich regulatory elements located adjacent to and 440 nucleotides downstream of the core poly(A) site of the intronless melanocortin receptor 1 gene are critical for efficient 3′ end processing. Mol. Cell. Biol., 27, 1568-1580.
17. Millevoi,S. and Vagner,S. (2010) Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation. Nucleic Acids Res., 38, 2757-2774.
18. Proudfoot,N. (2004) New perspectives on connecting messenger RNA 3′ end formation to transcription. Curr. Opin. Cell Biol., 16, 272-278.
19. Tian,B., Hu,J., Zhang,H. and Lutz,C.S. (2005) A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res., 33, 201-212. (Pubitemid 40276942)
20. Mayr,C. and Bartel,D.P. (2009) Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell, 138, 673-684.
21. Sandberg,R., Neilson,J.R., Sarma,A., Sharp,P.A. and Burge,C.B. (2008) Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science, 320, 1643-1647. (Pubitemid 351931255)
22. Sviderskaya,E.V., Gray-Schopfer,V.C., Hill,S.P., Smit,N.P., Evans-Whipp,T.J., Bond,J., Hill,L., Bataille,V., Peters,G., Kipling,D. et al. (2003) p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression. J. Natl Cancer Inst., 95, 723-732. (Pubitemid 36665500)
23. Levitt,N., Briggs,D., Gil,A. and Proudfoot,N.J. (1989) Definition of an efficient synthetic poly(A) site. Genes Dev., 3, 1019-1025.
24. Nunes,N.M., Li,W., Tian,B. and Furger,A. (2010) A functional human Poly(A) site requires only a potent DSE and an A-rich upstream sequence. EMBO J., 29, 1523-1536.
25. Greger,I.H., Demarchi,F., Giacca,M. and Proudfoot,N.J. (1998) Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter. Nucleic Acids Res., 26, 1294-1301.
26. Tan,C.P., McKee,K.K., Weinberg,D.H., MacNeil,T., Palyha,O.C., Feighner,S.D., Hreniuk,D.L., Van Der Ploeg,L.H., MacNeil,D.J. and Howard,A.D. (1999) Molecular analysis of a new splice variant of the human melanocortin-1 receptor. FEBS Lett., 451, 137-141. (Pubitemid 29231937)
27. Busca,R., Abbe,P., Mantoux,F., Aberdam,E., Peyssonnaux,C., Eychene,A., Ortonne,J.-P. and Ballotti,R. (2000) Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J., 19, 2900-2910. (Pubitemid 30386762)
28. Smalley,K. and Eisen,T. (2000) The involvement of p38 mitogen-activated protein kinase in the alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells. FEBS Lett., 476, 198-202. (Pubitemid 30410817)
29. Lutz,C.S. (2008) Alternative polyadenylation: a twist on mRNA 3′ end formation. ACS Chem. Biol., 3, 609-617.
30. Akiva,P., Toporik,A., Edelheit,S., Peretz,Y., Diber,A., Shemesh,R., Novik,A. and Sorek,R. (2006) Transcription-mediated gene fusion in the human genome. Genome Res., 16, 30-36. (Pubitemid 43048931)
31. Parra,G., Reymond,A., Dabbouseh,N., Dermitzakis,E.T., Castelo,R., Thomson,T.M., Antonarakis,S.E. and Guigó,R. (2006) Tandem chimerism as a means to increase protein complexity in the human genome. Genome Res., 16, 37-44. (Pubitemid 43048932)
32. Poulin,F., Brueschke,A. and Sonenberg,N. (2003) Gene fusion and overlapping reading frames in the mammalian genes for 4E-BP3 and MASK. J. Biol. Chem., 278, 52290-52297.
33. Magrangeas,F., Pitiot,G., Dubois,S., Bragado-Nilsson,E., Cherel,M., Jobert,S., Lebeau,B., Boisteau,O., Lethe,B., Mallet,J. et al. (1998) Cotranscription and intergenic splicing of human galactose-1-phosphate uridylyltransferase and interleukin-11 receptor alpha-chain genes generate a fusion mRNA in normal cells. Implication for the production of multidomain proteins during evolution. J. Biol. Chem., 273, 16005-16010.
34. Pradet-Balade,B., Medema,J.P., Lopez-Fraga,M., Lozano,J.C., Kolfschoten,G.M., Picard,A., Martinez,A.C., Garcia-Sanz,J.A. and Hahne,M. (2002) An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J., 21, 5711-5720. (Pubitemid 35315271)
35. Communi,D., Suarez-Huerta,N., Dussossoy,D., Savi,P. and Boeynaems,J.-M. (2001) Cotranscription and Intergenic Splicing of HumanP2Y 11 and SSF1 Genes. J. Biol. Chem., 276, 16561-16566.
36. Maeda,K., Horikoshi,T., Nakashima,E., Miyamoto,Y., Mabuchi,A. and Ikegawa,S. (2005) MATN and LAPTM are parts of larger transcription units produced by intergenic splicing: intergenic splicing may be a common phenomenon. DNA Res., 12, 365-372.
37. Lasa,M., Mahtani,K.R., Finch,A., Brewer,G., Saklatvala,J. and Clark,A.R. (2000) Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell. Biol., 20, 4265-4274.
38. Winzen,R., Kracht,M., Ritter,B., Wilhelm,A., Chen,C.Y., Shyu,A.B., Muller,M., Gaestel,M., Resch,K. and Holtmann,H. (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J., 18, 4969-4980. (Pubitemid 29443799)
39. Sanchez-Mas,J., Guillo,L.A., Zanna,P., Jimenez-Cervantes,C. and Garcia-Borron,J.C. (2005) Role of G protein-coupled receptor kinases in the homologous desensitization of the human and mouse Melanocortin 1 receptors. Mol. Endocrinol., 19, 1035-1048.
40. Sanchez-Laorden,B.L., Sanchez-Mas,J., Martinez-Alonso,E., Martinez-Menarguez,J.A., Garcia-Borron,J.C. and Jimenez-Cervantes,C. (2006) Dimerization of the human melanocortin 1 receptor: functional consequences and dominant-negative effects. J. Invest. Dermatol., 126, 172-181.
41. Katsetos,C.D., Herman,M.M. and Mork,S.J. (2003) Class III beta-tubulin in human development and cancer. Cell Motil Cytoskeleton, 55, 77-96. (Pubitemid 36627260)